MedPath

Treatment of Parental Anxiety Virtual Reality (VR)

Not Applicable
Recruiting
Conditions
Anxiety
Virtual Reality
Parents
Interventions
Behavioral: Virtual Reality headset with calming scenery
Registration Number
NCT05729347
Lead Sponsor
Stanford University
Brief Summary

The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care (i.e., no technology based distraction) for preventing anxiety in parental and pediatric populations

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Ages 18-99 (Patient's parents will be enrolled)
  • Able to consent
Exclusion Criteria
  • People who do not consent
  • Significant Cognitive Impairment
  • History of Severe Motion Sickness
  • Current Nausea
  • Seizures
  • Visual Problems Patients whose children are clinically unstable or require urgent/emergent intervention

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Virtual RealityVirtual Reality headset with calming sceneryParticipants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes
Primary Outcome Measures
NameTimeMethod
Procedural-Related AnxietyDuration of intervention, approximately 20-30 minutes

Validated questionnaires regarding anxiety will be administers pre- and post-intervention (i.e virtual reality) and compared to those in the control arm (i.e no virtual reality)

Secondary Outcome Measures
NameTimeMethod
State-Trait Anxiety Inventorybaseline, immediately after the intervention

The State-Trait Anxiety Inventory (STAI) is a validated self-report questionnaire consisting of two subscales that measure state anxiety (temporary condition) and trait anxiety (general tendency). Each subscale contains 20 items rated on a 4-point Likert scale. Scores range from 20 to 80 per subscale, with higher scores indicating greater anxiety.

Change in anxiety levelsbaseline, immediately after the intervention

Anxiety level measured by a Visual Analogue Scale - Anxiety (VAS-A) ranging from 0-10. Scale ranges from 0-10, with higher scores indicating higher anxiety levels.

Device satisfactionimmediately after intervention

To evaluate the overall impact of device satisfaction, participants will complete the self-developed satisfaction survey. Participants will rank each factor on a Likert scale from 1 = not at all to 5 = a lot.

Modified Pain Catastrophizing Scaleimmediately after intervention

Modified Pain Catastrophizing Scale(PCS); It is a self-report measure adapted from the Adult Pain Catastrophizing Scale used to assess negative thinking associated with pain. It contains 3 items rated on a 5-point scale ranging from 0 = "not at all" to 4 = "very much".

Trial Locations

Locations (1)

Lucile Parkard Children's Hospital

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath